# Replimune’s twice-rejected melanoma drug prevails in FDA adcomm

> **Newsylist Open Intelligence Dossier** · First detected: 2026-07-31 16:29 UTC · Category: Business · Sources: 3 · Current Velocity: 1.3

## Multi-Source Evidence Table
| Source Outlet | Headline | Published (UTC) | Verification URL |
|---|---|---|---|
| WSJ | Opinion | 2026-07-30 22:20 | [Source Link](https://news.google.com/rss/articles/CBMikwFBVV95cUxNeUM5bHBRZkMxT2xqUXhYUEtxSHk3V2ZvYmhUYWE1ci1KN1JTenBqUG9KWHBzS0VlWTh5UndLQ19peXNoNEdDdlJkUGU2VW5ZSDNkMTQxX25TbVBXclhNSXJaUnp5NFk1aHpKZjhLczhLUnpIUHUyVjM2c2NpQjhOSTNIdnhwWHUyeVpjTWlJb29WTWc?oc=5) |
| BioSpace | Replimune overcomes ‘messy data’ to secure positive adcomm vote for melanoma therapy | 2026-07-30 22:20 | [Source Link](https://news.google.com/rss/articles/CBMisAFBVV95cUxPX29hMDRRb2pmZ2dhTEstOGdDaXdDcTR6aHpZRVhaUXRIS1FYRkJ2MUFkcnEwdzNJX29tWFBaNnVLR0l4NHF0eVZZUUZKeVdsdnVtSmdrM1NnX3U3bDlBQ1FDVmQ3RUZQU2tYbTQ0dTlBVThaMWRXNzVzaE1BM2hock45RWpQQUlsZk1WVkw1b2x6Y1RLUDFhNURsU0VNSXVveG91Q014bGJ0R0xucExkVQ?oc=5) |
| Politico | Replimune gets a favorable vote after Capricor falls short | 2026-07-30 22:20 | [Source Link](https://news.google.com/rss/articles/CBMizwFBVV95cUxPV3dJcHFIQUhyLU5NenNhQS1PV1FXOFdkSHpJNXZBUUY2NXFHMkRSeEJQdF80dWZSZmxUbHlNVGNTVTN6STVydk1ydFhnN0VLMEdWdjJLYzZrNmFkMXNPajV2MFU2N0p0ckhNYmxDSDdHcnhCekc1d0x4Z2hVWXFud1RUV21tdEZJX0NLWEZncm1ZZW1sYWlfZnhXR2FnM05ZZFdVVEttWUVsVElTcUZFNVY1SjU3cll5eURmSjE3S3ZzVUgxbGpFYjcyTGN4Mzg?oc=5) |

---
*Canonical Source: https://www.newsylist.com/trend/2026-07-31/replimune-s-twice-rejected-melanoma-drug-prevails-in-fda-adcomm*
*Synthesized by Newsylist Open Intelligence Engine under E-E-A-T journalistic standards.*